Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke

<scp>CHARMM</scp>: A program for macromolecular energy, minimization, and dynamics calculations

Bernard R. Brooks, Robert E. Bruccoleri, Barry D. Olafson et al. · Journal of Computational Chemistry · 1983 · 14.9K citations

Engineering, Molecular Biology, Empirical Energy Function +21

Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

Jeffrey H. Hanke, Joseph P. Gardner, Robert L. Dow et al. · Journal of Biological Chemistry · 1996 · 1.9K citations · Full text

VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain

Zheng Gang Zhang, Li Zhang, Quan Jiang et al. · Journal of Clinical Investigation · 2000 · 1.3K citations · Full text

Discovery of <i>N</i>-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays

Louis J. Lombardo, Francis Y. Lee, Ping Chen et al. · Journal of Medicinal Chemistry · 2004 · 1.3K citations · Full text

Drug Target, Preclinical Assays, Pharmacotherapy +19

Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability

Brian P. Eliceiri, Robert Paul, Pamela L. Schwartzberg et al. · Molecular Cell · 1999 · 814 citations · Full text

Vegf-induced Angiogenesis, Vascular Permeability, Angiogenesis +10